骨髓
造血
医学
再生(生物学)
造血干细胞
间质细胞
胶质细胞源性神经生长因子
神经再生
神经营养因子
干细胞
化疗
神经保护
癌症研究
生物
免疫学
药理学
内科学
细胞生物学
受体
作者
Daniel Lucas,Christoph Scheiermann,Andrew T. Chow,Yuya Kunisaki,Ingmar Bruns,Colleen A. Barrick,Lino Tessarollo,Paul S. Frenette
出处
期刊:Nature Medicine
[Nature Portfolio]
日期:2013-05-05
卷期号:19 (6): 695-703
被引量:310
摘要
Many chemotherapy drugs cause sensory nerve damage as well as long-lasting damage to hematopoietic regeneration in the bone marrow. Paul Frenette and his colleagues show that this hematopoietic damage is caused by injury to bone marrow sympathetic nerve fibers, disrupting the hematopoietic stem cell niche. These findings point to the potential of neuroprotective agents in preserving hematopoietic function in chemotherapy-treated patients with cancer. Anticancer chemotherapy drugs challenge hematopoietic tissues to regenerate but commonly produce long-term sequelae. Chemotherapy-induced deficits in hematopoietic stem or stromal cell function have been described, but the mechanisms mediating hematopoietic dysfunction remain unclear. Administration of multiple cycles of cisplatin chemotherapy causes substantial sensory neuropathy. Here we demonstrate that chemotherapy-induced nerve injury in the bone marrow of mice is a crucial lesion impairing hematopoietic regeneration. Using pharmacological and genetic models, we show that the selective loss of adrenergic innervation in the bone marrow alters its regeneration after genotoxic insult. Sympathetic nerves in the marrow promote the survival of constituents of the stem cell niche that initiate recovery. Neuroprotection by deletion of Trp53 in sympathetic neurons or neuroregeneration by administration of 4-methylcatechol or glial-derived neurotrophic factor (GDNF) promotes hematopoietic recovery. These results demonstrate the potential benefit of adrenergic nerve protection for shielding hematopoietic niches from injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI